A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.
Times cited: 3
Recommendations for clinical trial development in mantle cell lymphoma.
Journal of the National Cancer Institute.
Times cited: 8
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
New England Journal of Medicine.
Times cited: 571